StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.72−0.04 (-4.65%)

Close on Nov 17, 2026Market cap $8.33MP/E –Yield –

Phio Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Phio Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was -$13.47M. For fiscal 2025 it was -$9.22M. The highest annual figure on record is -$7.36M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.22M–
FY2024Dec 31, 2024-$7.39M–
FY2023Dec 31, 2023-$10.82M–
FY2022Dec 31, 2022-$11.46M–
FY2021Dec 31, 2021-$13.51M–
FY2020Dec 31, 2020-$8.79M–
FY2019Dec 31, 2019-$8.99M–
FY2018Dec 31, 2018-$7.36M–
FY2017Dec 31, 2017-$14.06M–
FY2016Dec 31, 2016-$9.02M–
FY2015Dec 31, 2015-$10.24M–
FY2014Dec 31, 2014-$8.83M–
FY2013Dec 31, 2013-$20.95M–
FY2012Dec 31, 2012-$12.98M–
FY2011Dec 31, 2011-$12.77M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.27M–
Q1 FY2026Mar 31, 2026-$4.17M–
Q4 FY2025Dec 31, 2025-$2.53M–
Q3 FY2025Sep 30, 2025-$2.51M–
Q2 FY2025Jun 30, 2025-$2.31M–
Q1 FY2025Mar 31, 2025-$1.87M–
Q4 FY2024Dec 31, 2024-$1.67M–
Q3 FY2024Sep 30, 2024-$1.59M–
Q2 FY2024Jun 30, 2024-$1.91M–
Q1 FY2024Mar 31, 2024-$2.21M–
Q4 FY2023Dec 31, 2023-$1.90M–
Q3 FY2023Sep 30, 2023-$2.78M–
Q2 FY2023Jun 30, 2023-$2.55M–
Q1 FY2023Mar 31, 2023-$3.60M–
Q4 FY2022Dec 31, 2022-$2.73M–
Q3 FY2022Sep 30, 2022-$3.57M–
Q2 FY2022Jun 30, 2022-$2.52M–
Q1 FY2022Mar 31, 2022-$2.64M–
Q4 FY2021Dec 31, 2021-$3.45M–
Q3 FY2021Sep 30, 2021-$3.74M–
Q2 FY2021Jun 30, 2021-$2.68M–
Q1 FY2021Mar 31, 2021-$3.64M–
Q4 FY2020Dec 31, 2020-$2.46M–
Q3 FY2020Sep 30, 2020-$2.31M–
Q2 FY2020Jun 30, 2020-$1.67M–
Q1 FY2020Mar 31, 2020-$2.36M–
Q4 FY2019Dec 31, 2019-$2.67M–
Q3 FY2019Sep 30, 2019-$2.11M–
Q2 FY2019Jun 30, 2019-$2.06M–
Q1 FY2019Mar 31, 2019-$2.15M–
Q4 FY2018Dec 31, 2018-$1.73M–
Q3 FY2018Sep 30, 2018-$1.49M–
Q2 FY2018Jun 30, 2018-$1.90M–
Q1 FY2018Mar 31, 2018-$2.24M–
Q4 FY2017Dec 31, 2017-$1.99M–
Q3 FY2017Sep 30, 2017-$2.48M–
Q2 FY2017Jun 30, 2017-$2.51M–
Q1 FY2017Mar 31, 2017-$7.08M–
Q4 FY2016Dec 31, 2016-$2.34M–
Q3 FY2016Sep 30, 2016-$2.22M–

More Phio Pharmaceuticals figures

See a number that looks wrong?